1. Home
  2. ILAG vs XBIO Comparison

ILAG vs XBIO Comparison

Compare ILAG & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intelligent Living Application Group Inc.

ILAG

Intelligent Living Application Group Inc.

N/A

Current Price

$2.78

Market Cap

6.1M

ML Signal

N/A

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

N/A

Current Price

$2.26

Market Cap

5.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ILAG
XBIO
Founded
1981
N/A
Country
Hong Kong
United States
Employees
N/A
2
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1M
5.8M
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
ILAG
XBIO
Price
$2.78
$2.26
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
748.0
★ 100.9K
Earning Date
04-24-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 38.52
EPS
★ N/A
N/A
Revenue
N/A
★ $2,976,411.00
Revenue This Year
N/A
$2.81
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 19.04
52 Week Low
$0.27
$1.90
52 Week High
$7.19
$13.93

Technical Indicators

Market Signals
Indicator
ILAG
XBIO
Relative Strength Index (RSI) 44.31 35.14
Support Level $2.60 $2.14
Resistance Level $3.32 $2.62
Average True Range (ATR) 0.10 0.33
MACD 0.02 -0.17
Stochastic Oscillator 33.07 6.88

Price Performance

Historical Comparison
ILAG
XBIO

About ILAG Intelligent Living Application Group Inc.

Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Taiwan.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.

Share on Social Networks: